The world population is suffering a lot of genetic diseases. These diseases have been very hard to tackle so far. Fortunately, since a few decades viral vectors and gene therapies became more and more ...

Paul Cashen is a Senior Bioprocess Specialist at Pall, where he works on the downstream purification and analysis of viral vectors, monoclonal antibodies and recombinant proteins. From this experience ...

Polyplus-transfection SA has announced that Genethon, a not-for-profit biotherapy laboratory run by the French Muscular Dystrophy Association (AFM – Association Française contre les Myopathies) and ...

I’ve chatted with enough bots to know when something feels a little off. Sometimes, they’re overly flattering. Other times, weirdly evasive. And occasionally, they take a hard left into completely ...